Gene expression determinants of clinical outcome

被引:9
作者
Buckhaults, P [1 ]
机构
[1] Univ S Carolina, Sch Med, Dept Pathol & Microbiol, S Carolina Canc Ctr,Div Basic Res, Columbia, SC 29229 USA
关键词
cancer; gene expression profiling; microarray; molecular pathology; pathology; prognosis;
D O I
10.1097/01.cco.0000198022.76476.b2
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose of review Gene expression profiling of human cancers has produced a large amount of information that could aid physicians in making decisions related to the treatment of their patients. A number of recent studies have identified collections of genes and corresponding expression levels that correlate with the physical appearance and clinical behavior of all common human neoplasms. Recent findings This article will discuss emerging trends of study design and approaches to gene expression signature identification. Recently discovered gene expression signatures that correlate with cellular morphology, resistance to chemotherapy, and overall clinical course of disease are discussed. Summary The prospective evaluation of the predictive value of a number of gene signatures is now appropriate. Newly discovered gene expression signatures that correlate with disease clinical course should be independently evaluated. The timely reporting of both positive and negative results from such validation attempts will be crucial to the advancement of molecular pathology.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 16 条
[1]
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer [J].
Ayers, M ;
Symmans, WF ;
Stec, J ;
Damokosh, AI ;
Clark, E ;
Hess, K ;
Lecocke, M ;
Metivier, J ;
Booser, D ;
Ibrahim, N ;
Valero, V ;
Royce, M ;
Arun, B ;
Whitman, G ;
Ross, J ;
Sneige, N ;
Hortobagyi, GN ;
Pusztai, L .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2284-2293
[2]
Bladder cancer outcome and subtype classification by gene expression [J].
Blaveri, E ;
Simko, JP ;
Korkola, JE ;
Brewer, JL ;
Baehner, F ;
Mehta, K ;
DeVries, S ;
Koppie, T ;
Pejavar, S ;
Carroll, P ;
Waldman, FM .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4044-4055
[3]
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival [J].
Chiaretti, S ;
Li, XC ;
Gentleman, R ;
Vitale, A ;
Vignetti, M ;
Mandelli, F ;
Ritz, J ;
Foa, R .
BLOOD, 2004, 103 (07) :2771-2778
[4]
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients [J].
Dai, HY ;
van't Veer, L ;
Lamb, J ;
He, YD ;
Mao, M ;
Fine, BM ;
Bernards, R ;
de Vijver, MV ;
Deutsch, P ;
Sachs, A ;
Stoughton, R ;
Friend, S .
CANCER RESEARCH, 2005, 65 (10) :4059-4066
[5]
A molecular signature in superficial bladder carcinoma predicts clinical outcome [J].
Dyrskjot, L ;
Zieger, K ;
Kruhoffer, M ;
Thykjaer, T ;
Jensen, JL ;
Primdahl, H ;
Aziz, N ;
Marcussen, N ;
Moller, K ;
Orntoft, AF .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4029-4036
[6]
Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412
[7]
Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage [J].
Koehler, A ;
Bataille, F ;
Schmid, C ;
Ruemmele, P ;
Waldeck, A ;
Blaszyk, H ;
Hartmann, A ;
Hofstaedter, F ;
Dietmaier, W .
JOURNAL OF PATHOLOGY, 2004, 204 (01) :65-74
[8]
Synchronous global assessment of gene and protein expression in colorectal cancer progression [J].
Kwong, KY ;
Bloom, GC ;
Yang, I ;
Boulware, D ;
Coppola, D ;
Haseman, J ;
Chen, E ;
McGrath, A ;
Makusky, AJ ;
Taylor, J ;
Steiner, S ;
Zhou, J ;
Yeatman, TJ ;
Quackenbush, J .
GENOMICS, 2005, 86 (02) :142-158
[9]
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder:: Use of cDNA array analysis of gene expression profiles [J].
Modlich, O ;
Prisack, HB ;
Pitschke, G ;
Ramp, U ;
Ackermann, R ;
Bojar, H ;
Vögeli, TA ;
Grimm, MO .
CLINICAL CANCER RESEARCH, 2004, 10 (10) :3410-3421
[10]
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].
Paik, S ;
Shak, S ;
Tang, G ;
Kim, C ;
Baker, J ;
Cronin, M ;
Baehner, FL ;
Walker, MG ;
Watson, D ;
Park, T ;
Hiller, W ;
Fisher, ER ;
Wickerham, DL ;
Bryant, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826